PROGRESS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL PROGRAMS

Recombinant human serum albumin (OsrHSA) has emerged as a major innovation in the sphere of biopharmaceuticals, featuring promising advancements throughout several health care and industrial applications. With its structural similarity to naturally derived human serum albumin, OsrHSA offers a safer, a lot more reputable alternative for therapeutic